Historical unh News Stories
UNH Stock: Optum Reset, DOJ Probe, Medicare Gains!
UnitedHealth (UNH) saw mixed catalysts this week: improved Medicare Advantage star positioning and leadership changes bolstered sentiment, while rising medical costs and a DOJ criminal probe of billing practices keep pressure on margins and valuation. Analysts remain split — watch CMS star confirmations, Optum cost controls, and legal developments.
UnitedHealth Restores 2025 Outlook; Optum Woes
UnitedHealth reinstated its 2025 guidance this week, stabilizing UNH amid Optum Health margin pressure, Optum Rx growth with margin drag, ongoing DOJ scrutiny and a CMS Medicare Advantage payment boost.
UNH Rally: Medicare Boost, Optum Moves Drive Stock
UnitedHealth (UNH) saw renewed investor interest after a CMS Medicare Advantage benchmark increase and Optum operational changes. Key catalysts this week: a Medicare rate boost, Optum Rx payment-model updates and removal of some prior-authorizations, plus a major in‑network deal with a leading cancer center. These developments improve revenue visibility for Medicare Advantage and strengthen Optum’s competitive positioning, while legacy headwinds — recent earnings pressure, cost inflation, leadership shifts and a DOJ probe — continue to temper near-term sentiment.